NRC Health (NRC)
Healthcare • Health Information Services
StockNasdaqGSUnited StatesUS6373722023
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by NRC Health, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:57. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 02 Feb 2027 16:00 | 0.24 | — | — | Upcoming |
| 27 Oct 2026 16:00 | 0.18 | 0.21 | +16.7% | Beat |
| 28 Jul 2026 16:00 | 0.14 | 0.31 | +121.4% | Beat |
| 06 Aug 2019 17:00 | 0.26 | 0.29 | +11.5% | Beat |
| 07 May 2019 17:00 | 0.31 | 0.32 | +3.2% | Beat |
| 12 Feb 2019 17:00 | 1.05 | 0.30 | -71.4% | Miss |
| 06 Nov 2018 17:00 | 0.98 | 0.27 | -72.4% | Miss |
| 07 Aug 2018 19:00 | 0.22 | 0.28 | +27.3% | Beat |
| 01 May 2018 17:00 | 0.25 | 0.29 | +14.8% | Beat |
| 13 Feb 2018 18:00 | 0.22 | 0.23 | +5.6% | Beat |
| 07 Nov 2017 17:00 | 0.21 | 0.16 | -22.0% | Miss |
| 01 Aug 2017 17:00 | 0.20 | 0.23 | +14.5% | Beat |
| 02 May 2017 18:00 | 0.24 | 0.26 | +10.6% | Beat |
| 14 Feb 2017 17:00 | 0.22 | 0.24 | +7.4% | Beat |
| 01 Nov 2016 19:00 | 0.19 | 0.19 | 0.0% | In line |
| 02 Aug 2016 18:00 | 0.19 | 0.11 | -42.1% | Miss |
| 03 May 2016 18:00 | 0.21 | 0.12 | -42.9% | Miss |
| 10 Feb 2016 12:00 | 0.19 | 0.24 | +26.3% | Beat |
| 03 Nov 2015 17:00 | 0.18 | 0.17 | -5.6% | Miss |
| 04 Aug 2015 17:00 | 0.17 | 0.10 | -41.2% | Miss |
| 07 May 2015 17:00 | 0.20 | 0.14 | -30.0% | Miss |
| 10 Feb 2015 17:00 | 0.19 | 0.17 | -10.5% | Miss |
| 05 Aug 2014 17:00 | 0.09 | 0.10 | +11.1% | Beat |
| 05 Nov 2013 16:00 | 0.09 | 0.09 | 0.0% | In line |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 137.4M | -4.0% | 11.6M | 8.4% | 0.50 | -51.9% | 15.7M |
| 2024 | 143.1M | -3.7% | 24.8M | 17.3% | 1.04 | -16.8% | 19.2M |
| 2023 | 148.6M | -2.0% | 31M | 20.8% | 1.25 | -1.6% | 22.3M |
| 2022 | 151.6M | — | 31.8M | 21.0% | 1.27 | — | 26.4M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 24.02 | 27.60 | 23.51 | 26.12 | +9.61% | 1,221,619 | |
| Oct 2026 | 21.15 | 24.40 | 19.85 | 23.83 | +12.46% | 2,080,700 | |
| Sep 2026 | 20.94 | 22.36 | 19.18 | 21.19 | +1.19% | 2,704,700 | 0.1600 |
| Aug 2026 | 19.49 | 22.99 | 19.12 | 20.94 | +7.33% | 2,589,000 | |
| Jul 2026 | 21.60 | 23.68 | 17.88 | 19.51 | -9.55% | 2,017,300 | |
| Jun 2026 | 19.55 | 22.07 | 17.34 | 21.57 | +10.45% | 3,630,300 | 0.1600 |
| May 2026 | 16.36 | 20.21 | 16.26 | 19.53 | +18.65% | 2,289,400 | |
| Apr 2026 | 17.23 | 18.59 | 14.71 | 16.46 | -3.06% | 1,555,100 | |
| Mar 2026 | 13.22 | 18.31 | 12.77 | 16.98 | +26.62% | 2,546,700 | 0.1600 |
| Feb 2026 | 20.51 | 22.00 | 11.74 | 13.41 | -34.07% | 2,619,400 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- NRC Health: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 08 Nov 2026 23:35
- National Research: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 28 Oct 2026 18:34
- NRC Health (NRC) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 27 Oct 2026 23:02
- National Research Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 27 Oct 2026 22:04
- NRC Health Trades at a Discount: Should You Buy, Sell or Hold? (opens in a new tab) Zacks · 28 Sep 2026 17:35
- NRC Health's Dividend Analysis (opens in a new tab) GuruFocus.com · 25 Sep 2026 12:04
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 26.64 USD
- Market cap
- 577.4M
- Dividend yield
- 2.35%
- 5-year average yield
- 1.91%
- Payout ratio
- 237%
- Last dividend
- 0.1600 USD · 29 Dec 2026
- Next ex-dividend date
- 29 Dec 2026
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Health Information Services
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 25 Sep 2026 | 0.1600 USD |
| 26 Jun 2026 | 0.1600 USD |
| 27 Mar 2026 | 0.1600 USD |
| 26 Dec 2025 | 0.1600 USD |
| 8 older dividends: create a free account to see them | |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 9.8 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 5.6 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 0.8 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 6.5 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 3.0 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 2.2 / 5 |
|
- Score capped at 50: three or more warnings
- The dividend is above the earnings (payout 237%)
- Total debt has risen three years in a row
- Revenue has fallen two years in a row
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A). Warnings take 18 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 99.44× | Weak | 30.56× |
| P/E (forward) | 25.33× | Weak | 14.16× |
| Price / book | -62.44× | Weak | 3.5× |
| Price / sales | 3.96× | Fair | 3.33× |
| EV / EBITDA | 24.01× | Weak | 11.19× |
| Free cash flow yield | 3.6% | Fair | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 60.7% | Good | 54.9% |
| Operating margin | 23.2% | Good | 5.8% |
| Net margin | 4.5% | Weak | 1.2% |
| Return on equity | 248.1% | Good | 4.4% |
| Return on assets | 8.7% | Good | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | -3.2% | Weak | 10.1% |
| EPS growth / year | -26.7% | Weak | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 5.65× | Weak | 0.4× |
| Net debt / EBITDA | 3.59× | Weak | 1.46× |
| Interest cover | 4.74× | Fair | 2.17× |
| Current ratio | 0.64× | Weak | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 237% | Weak | 0% |
| Payout of free cash flow | 53.9% | Fair | 28.7% |
| Payout of free cash flow (3 years) | 102.7% | Weak | — |
| Dividend growth / year | -1.7% | Weak | 6.5% |
| Years of rising dividends | 1 | Weak | 1.5 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow NRC and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.